154 related articles for article (PubMed ID: 3948171)
1. Derivatives of 5,6-diphenylpyridazin-3-one: synthetic antimitotic agents which interact with plant and mammalian tubulin at a new drug-binding site.
Batra JK; Powers LJ; Hess FD; Hamel E
Cancer Res; 1986 Apr; 46(4 Pt 2):1889-93. PubMed ID: 3948171
[TBL] [Abstract][Full Text] [Related]
2. Structure-function studies with derivatives of 6-benzyl-1,3-benzodioxole, a new class of synthetic compounds which inhibit tubulin polymerization and mitosis.
Batra JK; Jurd L; Hamel E
Mol Pharmacol; 1985 Jan; 27(1):94-102. PubMed ID: 3965931
[TBL] [Abstract][Full Text] [Related]
3. Identification of novel antimitotic agents acting at the tubulin level by computer-assisted evaluation of differential cytotoxicity data.
Paull KD; Lin CM; Malspeis L; Hamel E
Cancer Res; 1992 Jul; 52(14):3892-900. PubMed ID: 1617665
[TBL] [Abstract][Full Text] [Related]
4. Spongistatin 1, a highly cytotoxic, sponge-derived, marine natural product that inhibits mitosis, microtubule assembly, and the binding of vinblastine to tubulin.
Bai R; Cichacz ZA; Herald CL; Pettit GR; Hamel E
Mol Pharmacol; 1993 Oct; 44(4):757-66. PubMed ID: 8232226
[TBL] [Abstract][Full Text] [Related]
5. Methylenedioxy-benzopyran analogs of podophyllotoxin, a new synthetic class of antimitotic agents that inhibit tubulin polymerization.
Batra JK; Kang GJ; Jurd L; Hamel E
Biochem Pharmacol; 1988 Jul; 37(13):2595-602. PubMed ID: 3390218
[TBL] [Abstract][Full Text] [Related]
6. Antimitotic antifungal compound benomyl inhibits brain microtubule polymerization and dynamics and cancer cell proliferation at mitosis, by binding to a novel site in tubulin.
Gupta K; Bishop J; Peck A; Brown J; Wilson L; Panda D
Biochemistry; 2004 Jun; 43(21):6645-55. PubMed ID: 15157098
[TBL] [Abstract][Full Text] [Related]
7. Tricyclic pyrone analogs: a new synthetic class of bifunctional anticancer drugs that inhibit nucleoside transport, microtubule assembly, the viability of leukemic cells in vitro and the growth of solid tumors in vivo.
Perchellet EM; Ladesich JB; Magill MJ; Chen Y; Hua DH; Perchellet JP
Anticancer Drugs; 1999 Jun; 10(5):489-504. PubMed ID: 10477169
[TBL] [Abstract][Full Text] [Related]
8. Tubulin-dependent hydrolysis of guanosine triphosphate as a screening test to identify new antitubulin compounds with potential as antimitotic agents: application to carbamates of aromatic amines.
Chi DM; Shahrik LK; Ho HH; Hamel E
Cancer Res; 1989 Mar; 49(6):1344-8. PubMed ID: 2924291
[TBL] [Abstract][Full Text] [Related]
9. Natural organic compounds that affect to microtubule functions.
Iwasaki S
Yakugaku Zasshi; 1998 Apr; 118(4):112-26. PubMed ID: 9564789
[TBL] [Abstract][Full Text] [Related]
10. [Immunofluorescent studies on cytoplasmic microtubule complex (CMTC) of Vero cells treated with 5,6-diphenylpyridazin-3-one derivatives].
Liu ZL
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1990 Jun; 12(3):213-6. PubMed ID: 1981866
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of antimitotic agents by quantitative comparisons of their effects on the polymerization of purified tubulin.
Hamel E
Cell Biochem Biophys; 2003; 38(1):1-22. PubMed ID: 12663938
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of action of E7010, an orally active sulfonamide antitumor agent: inhibition of mitosis by binding to the colchicine site of tubulin.
Yoshimatsu K; Yamaguchi A; Yoshino H; Koyanagi N; Kitoh K
Cancer Res; 1997 Aug; 57(15):3208-13. PubMed ID: 9242451
[TBL] [Abstract][Full Text] [Related]
13. Investigation of the mechanism of the interaction of tubulin with derivatives of 2-styrylquinazolin-4(3H)-one.
Lin CM; Kang GJ; Roach MC; Jiang JB; Hesson DP; Luduena RF; Hamel E
Mol Pharmacol; 1991 Nov; 40(5):827-32. PubMed ID: 1944246
[TBL] [Abstract][Full Text] [Related]
14. Interaction of estramustine with tubulin isotypes.
Laing N; Dahllöf B; Hartley-Asp B; Ranganathan S; Tew KD
Biochemistry; 1997 Jan; 36(4):871-8. PubMed ID: 9020786
[TBL] [Abstract][Full Text] [Related]
15. Two novel series of allocolchicinoids with modified seven membered B-rings: design, synthesis, inhibition of tubulin assembly and cytotoxicity.
Büttner F; Bergemann S; Guénard D; Gust R; Seitz G; Thoret S
Bioorg Med Chem; 2005 May; 13(10):3497-511. PubMed ID: 15848763
[TBL] [Abstract][Full Text] [Related]
16. Halichondrin B and homohalichondrin B, marine natural products binding in the vinca domain of tubulin. Discovery of tubulin-based mechanism of action by analysis of differential cytotoxicity data.
Bai RL; Paull KD; Herald CL; Malspeis L; Pettit GR; Hamel E
J Biol Chem; 1991 Aug; 266(24):15882-9. PubMed ID: 1874739
[TBL] [Abstract][Full Text] [Related]
17. Mitosis and microtuble assembly.
Jacobs M; Cavalier-Smith T
Biochem Soc Symp; 1977; (42):193-219. PubMed ID: 339920
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic selectivity of vinca alkaloids: a role for guanosine 5'-triphosphate?
Houghton PJ; Houghton JA; Bowman LC; Hazelton BJ
Anticancer Drug Des; 1987 Oct; 2(2):165-79. PubMed ID: 3329524
[TBL] [Abstract][Full Text] [Related]
19. Comparison of 1,2-dihydropyrido[3,4-b]pyrazines (1-deaza-7,8-dihydropteridines) with several other inhibitors of mitosis.
Bowdon BJ; Waud WR; Wheeler GP; Hain R; Dansby L; Temple C
Cancer Res; 1987 Mar; 47(6):1621-6. PubMed ID: 3815360
[TBL] [Abstract][Full Text] [Related]
20. Methoxy-substituted 3-formyl-2-phenylindoles inhibit tubulin polymerization.
Gastpar R; Goldbrunner M; Marko D; von Angerer E
J Med Chem; 1998 Dec; 41(25):4965-72. PubMed ID: 9836614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
